Mark E. Cartwright

2.0k citations

36 papers · 1.5k indexed · h-index 18

Impact in

Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Pediatrics, Perinatology and Child Health top 5%
- Pharmacological Effects and Toxicity Studies

Papers in ⓘ

Small Animals 5
Ophthalmology 4
- Glaucoma and retinal disorders 3

Co-authors: George R. Lankas (4 shared papers)Diane R. Umbenhauer (3 shared papers)L. David Wise (3 shared papers)Todd R. Pippert (2 shared papers)Gary P. O’Neill (1 shared paper)J. Frank (1 shared paper)Denis Riendeau (1 shared paper)Jillian F. Evans (1 shared paper)
Journals: Toxicologic Pathology (4 papers)Toxicology and Applied Pharmacology (3 papers)Journal of the American Veterinary Medical Association (3 papers)Investigative Ophthalmology & Visual Science (3 papers)Experimental Dermatology (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mark E. Cartwright

34 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark E. Cartwright

Since Specialization

Citations

This map shows the geographic impact of Mark E. Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cartwright more than expected).

Fields of papers citing papers by Mark E. Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cartwright. The network helps show where Mark E. Cartwright may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Cartwright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Cartwright Line = papers co-authored together Mark E. Cartwright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts Gastroenterology ·Stacia Kargman, S. Charleson, Mark E. Cartwright, J. Frank, Denis Riendeau, Joseph A. Mancini, Jillian F. Evans, Gary P. O’Neill	1996	400
2	Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice Reproductive Toxicology ·George R. Lankas, L. David Wise, Mark E. Cartwright, Todd R. Pippert, Diane R. Umbenhauer	1998	237
3	P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity Toxicology and Applied Pharmacology ·George R. Lankas, Mark E. Cartwright, Diane R. Umbenhauer	1997	155
4	Identification of a P-Glycoprotein-Deficient Subpopulation in the CF-1 Mouse Strain Using a Restriction Fragment Length Polymorphism Toxicology and Applied Pharmacology ·Diane R. Umbenhauer, George R. Lankas, Todd R. Pippert, L. David Wise, Mark E. Cartwright, Steven J. Hall, Carolann M. Beare	1997	89
5	Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys American Journal of Physiology-Renal Physiology ·Raymond E. Gibson, Holly H. Thorpe, Mark E. Cartwright, John D. Frank, Terry W. Schorn, Patricia B. Bunting, Peter K. S. Siegl	1991	56
6	The effects of three different demineralization agents on osteopontin localization in adult rat bone using immunohistochemistry Histochemistry ·John D. Frank, R. Balena, Pat Masarachia, J.G. Seedor, Mark E. Cartwright	1993	54
7	Exploratory drug safety: A discovery strategy to reduce attrition in development Journal of Pharmacological and Toxicological Methods ·Alan Bass, Mark E. Cartwright, Craig Mahon, Richard A. Morrison, Ronald D. Snyder, Paul E. McNamara, Prudence K. Bradley, Yingying Zhou, John Hunter	2009	50
8	A model for the control of testosterone secretion Journal of Theoretical Biology ·Mark E. Cartwright, Masud Husain	1986	45
9	Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice Clinical Pharmacology & Therapeutics ·Mark E. Cartwright, Steven E. Cohen, Joseph C. Fleishaker, Sedigheh Madani, James F. McLeod, Bret J. Musser, Stephen A. Williams	2010	42
10	Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM^® transgenic mice Carcinogenesis ·Richard D. Storer, Mark E. Cartwright, W. O. Cook, Keith A. Soper, Warren W. Nichols	1995	31
11	Recombinant E1-Deleted Adenovirus-Mediated Gene Therapy for Cancer: Efficacy Studies with p53 Tumor Suppressor Gene and Liver Histology in Tumor Xenograft Models Human Gene Therapy ·Loretta L. Nielsen, Maya Gurnani, Jameel Syed, Janet Dell, Barbara Hartman, Mark E. Cartwright, Robert C. Johnson	1998	31
12	Pharmacological Characterization of Postjunctional α-Adrenoceptors in Human Nasal Mucosa American Journal of Rhinology ·Michel R. Corboz, Maria A. Rivelli, Lori A. Varty, Jennifer C. Mutter, Mark E. Cartwright, Charles A. Rizzo, Stephen Eckel, John C. Anthes, John A. Hey	2005	31
13	Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy. PubMed ·Mark E. Cartwright, Roger S. Jaenke	1988	27
14	Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure Drug Discovery Today ·John Higgins, Mark E. Cartwright, Allen C. Templeton	2012	24
15	Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species Molecular Pharmaceutics ·Pierre Daublain, Kung‐I Feng, Michael D. Altman, Iain Martin, Suman Mukherjee, Rebecca Nofsinger, Alan B. Northrup, Richard A. Tschirret-Guth, Mark E. Cartwright, Caroline McGregor	2017	20
16	α2-adrenoceptor agonists as nasal decongestants Pulmonary Pharmacology & Therapeutics ·Michel R. Corboz, Jennifer C. Mutter, Maria A. Rivelli, Garfield G. Mingo, Robbie L. McLeod, LoriAnn M Varty, Yanlin Jia, Mark E. Cartwright, John A. Hey	2006	19
17	Phospholipidosis in Neurons Caused by Posaconazole, without Evidence for Functional Neurologic Effects Toxicologic Pathology ·Mark E. Cartwright, Janet Petruska, Joseph C. Arezzo, Doyle W. Frank, Mona S. Litwak, Richard E. Morrissey, J. S. Macdonald, Thomas E. Davis	2009	18
18	Comparison of renal biopsy techniques in dogs Journal of the American Veterinary Medical Association ·Lori A. Wise, Timothy A. Allen, Mark E. Cartwright	1989	17
19	Society of Toxicologic Pathology Position Paper: Diet as a Variable in Rodent Toxicology and Carcinogenicity Studies Toxicologic Pathology ·James B. Nold, Kevin P. Keenan, Abraham Nyska, Mark E. Cartwright	2001	16
20	Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1) Bioorganic & Medicinal Chemistry Letters ·Yongqi Deng, Zhiwei Yang, Gerald W. Shipps, Sie‐Mun Lo, Robert West, Joyce Hwa, Shuqin Zheng, Constance Farley, Jean E. Lachowicz, Margaret van Heek, Alan Bass, Dinesh P. Sinha, Craig R. Mahon, Mark E. Cartwright	2012	15

About Mark E. Cartwright

Mark E. Cartwright is a scholar working on Small Animals, Ophthalmology, Nephrology, Pharmacology and Pharmaceutical Science, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Glaucoma and retinal disorders (3 papers), Receptor Mechanisms and Signaling (3 papers), Ocular Surface and Contact Lens (3 papers), Renal Diseases and Glomerulopathies (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Ophthalmology and Eye Disorders (3 papers). The work is most often cited by research in Pharmacology (380 citations), Pediatrics, Perinatology and Child Health (300 citations), Oncology (407 citations), Small Animals (108 citations) and Pharmacology (110 citations). Mark E. Cartwright has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include George R. Lankas, Diane R. Umbenhauer, L. David Wise, Todd R. Pippert, Gary P. O’Neill, J. Frank, Denis Riendeau, Jillian F. Evans, S. Charleson and Stacia Kargman. Their work appears in journals such as Toxicologic Pathology, Toxicology and Applied Pharmacology, Journal of the American Veterinary Medical Association, Investigative Ophthalmology & Visual Science and Experimental Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact